Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1 clinical trials · Condition
◉ Watch Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Identification of Early Markers of Response and Resistance to Trastuzumab (NCT01834950) | Gustave Roussy, Cancer Campus, Grand Paris | 2013-03-27 |
Track Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.